Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?

被引：0
|
作者：
GianMaria Miolo
Ettore Bidoli
Davide Lombardi
Davide Adriano Santeufemia
Giampiero Capobianco
Francesco Dessole
Simona Scalone
Simon Spazzapan
Roberto Sorio
Gianna Tabaro
Andrea Veronesi
机构：
[1] Centro di Riferimento Oncologico,Department of Oncology, Division of Medical Oncology C
[2] National Cancer Institute,Epidemiology and Biostatistics Unit
[3] Centro di Riferimento Oncologico,Department of Oncology, Division of Medical Oncology
[4] National Cancer Institute,undefined
[5] Pordenone Hospital,undefined
[6] Gynecologic and Obstetric Clinic,undefined
[7] University of Sassari,undefined
来源：
Archives of Gynecology and Obstetrics | 2012年 / 285卷
关键词：
Chemotherapy; Dose density; Ovarian carcinoma; Weekly paclitaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：499 / 503
页数：4
相关论文
共 50 条
  • [41] Effect of weekly administration of bevacizumab, eribulin, and oxalilplatin in patients with heavily pretreated serous ovarian carcinoma.
    Ikeda, Yuji
    Takano, Masashi
    Sasaki, Naoki
    Kita, Tsunekazu
    Kikuchi, Yoshihiro
    Kudoh, Kazuya
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] ABSENCE OF CUMULATIVE BONE-MARROW SUPPRESSION IN HEAVILY PRETREATED OVARIAN-CANCER PATIENTS UNDERGOING SALVAGE CHEMOTHERAPY WITH PACLITAXEL
    PEARL, ML
    JOHNSTON, CM
    REYNOLDS, RK
    ROBERTS, JA
    ONCOLOGY, 1995, 52 (05) : 407 - 412
  • [43] The Combination of Weekly Carboplatin and Paclitaxel is Active and Tolerated for the Treatment of Advanced Ovarian Cancer in Elderly Patients
    Lugini, A.
    Pace, R.
    Capparella, V.
    Ciorra, A. A.
    Sciacca, V.
    Pistillucci, G.
    Rossi, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S538 - S538
  • [44] Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients
    Jimenez, Begona
    Trigo, Jose M.
    Pajares, Bella I.
    Saez, Maria I.
    Quero, Cristina
    Navarro, Victor
    Llacer, Casilda
    Medina, Laura
    Rueda, Antonio
    Alba, Emilio
    ORAL ONCOLOGY, 2013, 49 (02) : 182 - 185
  • [45] Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer
    Takano, M
    Kikuchi, Y
    Kita, T
    Suzuki, M
    Ohwada, M
    Yamamoto, T
    Yamamoto, K
    Inoue, H
    Shimizu, K
    ANTICANCER RESEARCH, 2002, 22 (03) : 1833 - 1838
  • [46] Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer (ROC).
    Boumedien, Feriel
    Adam, Jean-Philippe
    Akkour, Khalid
    LeTarte, Nathalie
    Provencher, Diane M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [47] Salvage therapy with topotecan (topo) of heavily pretreated ovarian cancer patients (hpocp).
    Wcislo, GB
    Bodnar, L
    Miedzinska-Maciejewska, M
    Szczylik, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 484S - 484S
  • [48] Pegylated liposomal doxorubicin (PLD) in heavily pretreated epithelial ovarian cancer patients
    Gorumlu, Gurbuz
    Kucukzeybek, Yuksel
    Karabulut, Bulent
    Terek, Mustafa C.
    Uslu, Ruchan
    Sanli, Ulus A.
    Akman, Levent
    Ozsaran, Aydin
    Dikmen, Yilmaz
    Goker, Erdem
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [49] WEEKLY PACLITAXEL-CARBOPLATINUM IS EFFECTIVE IN PLATINUM-RESISTANT OVARIAN CANCER PATIENTS AFTER PREVIOUS WEEKLY PACLITAXEL
    Concin, N.
    Salihi, R.
    Lage, T.
    Van Nieuwenhuysen, E.
    Neven, P.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 664 - 664
  • [50] Weekly Cisplatin plus Capecitabine is an active regimen in heavily pretreated advanced breast cancer patients
    Donadio, Michela
    Beano, Alessandra
    Ardine, Mara
    Bonardi, Simone
    Mistrangelo, Marinella
    Polimeni, Maria A.
    Castiglione, Federico
    Forti, Laura
    Bottini, Alberto
    Bertetto, Oscar
    ANNALS OF ONCOLOGY, 2004, 15 : 46 - 46
12345